Cramer Rosenthal Mcglynn LLC Quidel Ortho Corp Transaction History

Cramer Rosenthal Mcglynn LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$58.16 - $75.44 $2.02 Million - $2.62 Million	-34,785 Reduced 8.83%	359,126 $26.5 Million
Q3 2023 Nov 13, 2023	BUY	$70.9 - $88.63 $1.34 Million - $1.67 Million	18,869 Added 5.03%	393,911 $28.8 Million
Q2 2023 Aug 14, 2023	BUY	$81.09 - $94.16 $4.15 Million - $4.82 Million	51,238 Added 15.82%	375,042 $31.1 Million
Q1 2023 May 12, 2023	BUY	$82.98 - $91.46 $7.17 Million - $7.9 Million	86,356 Added 36.37%	323,804 $28.8 Million
Q4 2022 Feb 13, 2023	BUY	$66.93 - $97.5 $3.74 Million - $5.45 Million	55,901 Added 30.79%	237,448 $20.3 Million
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $1.56 Million - $2.41 Million	22,366 Added 14.05%	181,547 $13 Million
Q2 2022 Aug 12, 2022	BUY	$89.06 - $117.64 $14.2 Million - $18.7 Million	159,181 New	159,181 $15.5 Million

286

67.6M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.91B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.